Long-acting injectable antipsychotics. Case studies Case report

Abstract

Nonadherence to medications is a tremendous problem in schizophrenia because patients at the very onset have neurocognitive deficits, especially lack of insight and they may not understand that they have to take systematically antipsychotic medicines. Because of that, injectable long-acting antipsychotics are useful as once they’re administered, long-term clinical improvement is guaranteed. Actually, long-acting formulation offers some added benefits of a more steady level of drug in the patient’s system, higher efficacy, lower intolerability, and impressive improvement of adherence. As long-acting second-generation antipsychotics are more and more popular, the idea to make the collection of case studies with long-acting antipsychotics was put forward. The article presents the characteristics of patients that received the long-acting antipsychotics in the treatment.